APLN and atherosclerosis: Chun and colleagues showed that apelin decreases atherosclerosis progression, partly by increasing vascular NO expression, consequently decreasing ROS production13, while Fraga-Silva and collaborators37 show that apelin-13 intraperitoneal administration promoted the stabilization of atherosclerotic plaques, as well as the decrease of serum lipid content.